← Back to Search

Telehealth Diet Management for Stomach Cancer Post-Surgery

N/A
Waitlist Available
Led By Jae Y Kim
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The ability to understand English or Spanish
Age criterion for this trial is based on the National Institute of Health (NIH's) age criteria, which defines an adult as individuals aged 21 years and over. There are no restrictions related to performance status or life expectancy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will see if a diet intervention can help with nutrition and quality of life after surgery for esophagus or stomach cancer. The study could help patients get more information and support on eating after surgery.

Who is the study for?
This trial is for adults over 21 who've had surgery to remove stomach or gastroesophageal junction cancer and are starting to eat orally again. Participants must understand English or Spanish, be able to give informed consent, and participate in telehealth sessions. Those unable to follow the study's safety requirements can't join.
What is being tested?
The trial examines if a diet support program delivered via telehealth improves nutrition and life quality after esophagus or stomach cancer surgery. It involves questionnaires, virtual visits, and follows best practices for dietary management post-surgery.
What are the potential side effects?
Since this study focuses on dietary support through telehealth rather than medication, traditional side effects aren't expected. However, participants may experience discomfort discussing their health or using technology for communication.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can understand English or Spanish.
Select...
I am 21 years old or older.
Select...
I had surgery to remove stomach or GE junction cancer.
Select...
I am 21 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of the Telehealth Intervention - Percent Completion
Feasibility of the Telehealth Intervention - Percent Participation
Objective measures of patient nutrition - Albumin levels
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (telehealth session, guidebook)Experimental Treatment2 Interventions
Patients receive 4 telehealth sessions over 1 hour each over 4 months. Patients also receive an intervention guidebook.
Group II: Arm II (standard nutritional support)Active Control2 Interventions
Patients receive standard nutritional support.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,023,117 Total Patients Enrolled
City of Hope Medical CenterLead Sponsor
602 Previous Clinical Trials
1,923,394 Total Patients Enrolled
Jae Y KimPrincipal InvestigatorCity of Hope Medical Center

Media Library

Telemedicine Visit Clinical Trial Eligibility Overview. Trial Name: NCT05203627 — N/A
Gastroesophageal Junction Adenocarcinoma Research Study Groups: Arm II (standard nutritional support), Arm I (telehealth session, guidebook)
Gastroesophageal Junction Adenocarcinoma Clinical Trial 2023: Telemedicine Visit Highlights & Side Effects. Trial Name: NCT05203627 — N/A
Telemedicine Visit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05203627 — N/A
~0 spots leftby Dec 2024